Protein Expression Market by Product (Instruments, Reagents, Kits, Consumables, Software, Services), System Type (Mammalian, Insect, Yeast), Workflow (Cloning, Translation, PTM), Scale, Protein Type, Application, Competition - Global Forecast to 2031

icon1
USD 7.65 BN
MARKET SIZE, 2031
icon2
CAGR 8.3%
(2026-2031)
icon3
500
REPORT PAGES
icon4
560
MARKET TABLES

PROTEIN EXPRESSION MARKET SIZE, SHARE & GROWTH SNAPSHOT

protein-expression-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global protein expression market is projected to grow from USD 5.14 billion in 2026 to USD 7.65 billion by 2031, at a CAGR of 8.3% during the forecast period. The market was valued at USD 4.74 billion in 2025. The protein expression market encompasses the technologies, products, and services required for protein production, purification, and analysis. The market includes various expression systems such as mammalian, bacterial, yeast, insect, plant-based, algal, and cell-free platforms, along with vectors, transfection reagents, cell culture media, purification kits, analytical instruments, and characterization tools. It supports pharmaceutical, biotechnology, academic, CRO/CDMO, and industrial applications, including drug discovery, therapeutic development, vaccine production, biochemical research, and applications across food, cosmetics, and textile industries.

KEY TAKEAWAYS

  • BY REGION
    North America accounted for the largest market share, by region, in 2025: 42.4%.
  • BY OFFERING
    By offering, in 2025, the product segment had the largest share of 81.8%.
  • BY END USER
    Pharmaceutical & biotechnology companies dominated the the protein expression products market in 2025 with a share of 32.5%.
  • COMPETITIVE LANDSCAPE - Key Players
    Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and Danaher Corporation (US) were identified as some of the star players in the global protein expression market, given their strong market share and product and service footprint.
  • COMPETITIVE LANDSCAPE - Startups
    RayBiotech, Inc. (US) and Oxford Expression Technologies Ltd (UK) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The global protein expression market is expanding steadily, driven by growing demand for recombinant proteins and biologics, increasing investments in biopharmaceutical research and manufacturing, and rising adoption of advanced expression systems and protein production technologies across research, development, and commercial manufacturing.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The protein expression market is advancing steadily, driven by innovations in expression technologies, cell culture systems, automation, bioprocessing platforms, and evolving regulatory standards aligned with increasingly complex biologics development. The growing global demand for recombinant proteins, monoclonal antibodies, vaccines, biosimilars, and advanced therapies is accelerating the need for high-yield, scalable, and reliable protein production solutions. Expanding adoption of advanced mammalian, microbial, insect, yeast, and cell-free expression systems is supporting more efficient protein production, purification, and characterization workflows. Automated bioprocessing platforms, AI-driven optimization tools, and scalable manufacturing technologies are improving production efficiency, product quality, and process consistency while supporting regulatory compliance and commercial biologics manufacturing across major biopharmaceutical markets.

protein-expression-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing global biologics and biosimilars pipeline
  • Rising government and venture capital R&D funding
RESTRAINTS
Impact
Level
  • High capital and operational costs
OPPORTUNITIES
Impact
Level
  • Emerging algal expression systems and broader adoption of platforms such as cell-free, plant-based expression systems
  • AI/ML-driven expression optimization
CHALLENGES
Impact
Level
  • Scalability challenge from bench to GMP manufacturing

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing global biologics and biosimilar pipeline

Increasing global biologics and biosimilar pipelines are driving demand for advanced protein expression systems, scalable recombinant protein production, and high-yield bioprocessing technologies to support therapeutic development, vaccine manufacturing, and commercial biologics production.

Restraint: High capital and operational costs

High capital investment requirements for bioprocessing infrastructure, specialized instruments, cell culture systems, and purification technologies, as well as operational expenses related to reagents, media, and the skilled workforce, continue to restrain market expansion.

Opportunity: Emerging algal expression systems and broader adoption of platforms such as cell-free, plant-based expression systems

Emerging algal, plant-based, and cell-free expression systems are creating new opportunities for sustainable, cost-effective, and rapid recombinant protein production, supporting expanding applications in therapeutics, industrial enzymes, and synthetic biology.

Challenge: Scalability challenge from bench to GMP manufacturing

Scaling protein expression workflows from laboratory research to GMP-compliant commercial manufacturing remains challenging due to process variability, maintaining protein quality, ensuring batch consistency, and optimizing large-scale upstream and downstream bioprocessing operations.

PROTEIN EXPRESSION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides the Gibco ExpiCHO Expression System, which combines high-expressing CHO cells, chemically defined serum-free medium, optimized feed, and transfection reagent for transient mammalian protein expression. The system supports high-yield production of recombinant proteins and antibodies. Enables rapid mammalian protein production with improved titers, helping researchers accelerate antibody screening, recombinant protein generation, and early biologics development.
Provides CHOZN cell line engineering and development services using CHO cell lines, ZFN-based genome engineering, and media/feed platforms for recombinant protein production. Helps reduce biomanufacturing timelines and development cost by enabling high-producing CHO cell lines and optimized upstream workflows.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The global protein expression market is a highly interconnected ecosystem in which biopharmaceutical companies, biotechnology firms, academic institutes, and research organizations collaborate to develop and produce recombinant proteins, antibodies, vaccines, and therapeutic biologics. Expression system providers and technology companies offer advanced solutions, including microbial, mammalian, yeast, insect, and cell-free expression platforms, along with optimized vectors, reagents, and bioprocessing technologies. Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) support protein production, scale-up, purification, and characterization across research and commercial manufacturing stages. Regulatory authorities and healthcare systems across regions such as North America and Europe establish stringent quality and manufacturing standards, driving innovation, compliance, and the safe commercialization of protein-based therapeutics and biologics.

protein-expression-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

protein-expression-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Global Protein Expression Market, by Offering

In 2025, products accounted for the largest share of the market due to strong demand for reagents, kits, expression vectors, competent cells, and instruments used across recombinant protein production workflows. The continuous use of consumables in protein engineering, cell culture, transfection, and purification processes, together with increasing biologics R&D activities, supported the broad adoption of products across research and manufacturing environments.

Global Protein Expression Market, by Type

Mammalian expression systems held the largest share of the market in 2025 due to their ability to produce complex proteins with proper post-translational modifications, protein folding, and glycosylation patterns. Their widespread use in producing biologics such as recombinant proteins, vaccines, and monoclonal antibodies has increased adoption among pharmaceutical and biotechnology companies.

Global Protein Expression Market, by Workflow

Extraction, purification, and characterization represented the largest workflow segment in 2025 due to the critical need for high-purity proteins and analytical validation during research and commercial manufacturing. Growing emphasis on protein quality, structural analysis, and downstream processing efficiency contributed to segment dominance.

Global Protein Expression Market, by Scale of Operations

Discovery and research accounted for the largest share of the market in 2025 due to the extensive use of recombinant proteins in target identification, biomarker discovery, functional studies, and early-stage drug development. Increased investments in proteomics and biologics research further accelerated demand at the discovery stage.

Global Protein Expression Market, by Protein Modality

Monoclonal antibodies (mAbs) and derivatives held the largest share of the market in 2025 owing to their expanding use in oncology, autoimmune disorders, and targeted therapeutics. The growing development of biosimilars, antibody-drug conjugates, and next-generation antibody formats has driven substantial demand for high-yield expression platforms.

Global Biologics Saftey Testing Product Market, by Application

Therapeutic applications accounted for the largest share of the market in 2025, driven by increasing development of biologics, recombinant proteins, vaccines, and precision medicines. The rising prevalence of chronic diseases and the growing demand for protein-based therapeutics have significantly accelerated market growth.

Global Protein Expression Products Market, by End User

Pharmaceutical and biotechnology companies accounted for the largest share of the protein expression products market in 2025, driven by rising investment in biologics discovery and manufacturing, increasing demand for recombinant therapeutics, and high utilization of protein expression reagents, vectors, and analytical platforms across development pipelines.

Global Protein Expression Services Market, by End User

Pharmaceutical and biotechnology companies also dominated the services market in 2025, driven by the increasing outsourcing of protein engineering, cell line development, custom expression, and process optimization to specialized service providers and CDMOs. The development of therapeutic development programs and the need for scalable expertise further supported service adoption.

REGION

Asia Pacific to be fastest-growing region in market during forecast period

During the forecast period, the Asia Pacific is expected to witness rapid growth in the protein expression market due to expanding biopharmaceutical manufacturing, rising biotechnology investments, increasing biologics and biosimilar production, and growing adoption of advanced expression systems. Expanding CRO/CDMO services and technological advancements in protein production further support regional market growth.

protein-expression-market Region

PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX

Thermo Fisher Scientific is the star player, driven by its broad portfolio of protein expression systems, cell culture media, reagents, vectors, and purification technologies supporting recombinant protein and biologics production. The company maintains its leadership through continuous technological innovation, strong global distribution networks, and strategic collaborations with biopharmaceutical and research organizations. Eurofins Scientific is an emerging leader, supported by its expanding bioanalytical, protein characterization, and contract research capabilities. The company’s growing focus on biologics development services, advanced analytical platforms, and partnerships with biotechnology and pharmaceutical companies positions it strongly to benefit from the rising demand for outsourced protein expression and characterization services.

protein-expression-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 4.74 Billion
Market Forecast in 2026 (Value) USD 5.14 Billion
Market Forecast in 2031 (Value) USD 7.65 Billion
Growth Rate CAGR of 8.3 from 2026-2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering:
    • Products
    • Services
  • By Type:
    • Mammalian Cell Expression Systems
    • Prokaryotic Cell Expression Systems
    • Insect Cell Expression Systems
    • Yeast Expression Systems
    • Cell Free Expression Systems
    • Algal & Plant-based expression systems
  • By Workflow:
    • Cloning & Transfection
    • Transcription
    • Translation
    • & Post-translation Modification
    • Extraction
    • Purification
    • & Characterization
  • By Scale of Operation:
    • Discovery & Research
    • Preclinical & Characterization
    • Process Development & Pilot
  • By Protein Modality:
    • mAbs & derivatives
    • Recombinant Therapeutic Proteins
    • Vaccines
    • Enzymes & Catalytic proteins
    • Other Protein Modalities
  • By Application:
    • Therapeutic
    • Research
    • Industrial
    • Diagnostic
  • By Product End User:
    • Pharmaceutical & Biotechnology Companies
    • CROs & CDMOs
    • Academic & Research Institutes
    • Other End Users
  • By Service End User:
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa

WHAT IS IN IT FOR YOU: PROTEIN EXPRESSION MARKET REPORT CONTENT GUIDE

protein-expression-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Evaluate competitive positioning of key players in the protein expression market Benchmarked leading companies across expression systems, reagents, vectors, cell lines, media, purification technologies, and contract services based on technology, workflow coverage, geographic reach, and end-user focus Identifies competitive gaps, partnership opportunities, and differentiation strategies
Assess high-growth expression systems and technology opportunities Evaluated growth potential across mammalian, microbial, insect, yeast, plant-based, and cell-free systems, including AI-driven optimization and GMP-grade protein production Supports investment prioritization, product development, and service expansion strategies

RECENT DEVELOPMENTS

  • April 2026 : Thermo Fisher launched the Gibco CHOvantage GS Cell Line Development Kit, an integrated CHO cell-line development platform for development and recombinant protein expression
  • October 2025 : Merck announced the acquisition of JSR Life Sciences’ chromatography business to expand Protein A resin and downstream purification capabilities for biologics and recombinant protein manufacturing

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
66
2
EXECUTIVE SUMMARY
 
 
 
 
 
71
3
PREMIUM INSIGHTS
 
 
 
 
 
77
4
MARKET OVERVIEW
Explore groundbreaking innovations driving the protein expression market amid cost and scalability challenges.
 
 
 
 
 
80
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING GLOBAL BIOLOGICS AND BIOSIMILARS PIPELINE
 
 
 
 
 
 
4.2.1.2
RISING GOVERNMENT AND VENTURE CAPITAL R&D FUNDING
 
 
 
 
 
 
4.2.1.3
CONTINUOUS INNOVATION IN EXPRESSION TECHNOLOGIES
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH CAPITAL AND OPERATIONAL COSTS
 
 
 
 
 
4.2.3
OPPORTUNITY
 
 
 
 
 
 
 
4.2.3.1
EMERGING ALGAL EXPRESSION SYSTEMS AND RISING ADOPTION OF ADVANCED PLATFORMS
 
 
 
 
 
 
4.2.3.2
AL/ML-DRIVEN EXPRESSION OPTIMIZATION
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
SCALABILITY CHALLENGES FROM BENCH TO GMP MANUFACTURING
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive dynamics and pricing shifts in the evolving global protein expression market landscape.
 
 
 
 
 
87
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL PROTEIN EXPRESSION MARKET
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.3.1
PROTEIN EXPRESSION PRODUCTS
 
 
 
 
 
 
5.3.2
PROTEIN EXPRESSION SERVICES
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
 
 
 
 
 
 
5.5.2
INDICATIVE SELLING PRICE, BY REGION, 2025
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO FOR HS CODE 902781
 
 
 
 
 
 
5.6.2
EXPORT SCENARIO FOR HS CODE 902781
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.9
INVESTMENT/FUNDING SCENARIO
 
 
 
 
 
 
5.10
IMPACT OF US TARIFFS—PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
 
 
5.10.1
INTRODUCTION
 
 
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.10.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.10.4.1
NORTH AMERICA
 
 
 
 
 
 
5.10.4.2
EUROPE
 
 
 
 
 
 
5.10.4.3
ASIA PACIFIC
 
 
 
 
 
5.10.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.10.5.1
PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.10.5.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
5.10.5.3
CROS & CDMOS
 
 
 
 
5.11
BIOMANUFACTURING CAPACITY
 
 
 
 
 
 
5.12
NIH FUNDING FOR PROTEIN-RELATED RESEARCH
 
 
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations revolutionize protein expression, unlocking future applications and market potential.
 
 
 
 
 
108
 
6.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
RECOMBINANT DNA TECHNOLOGY
 
 
 
 
 
 
6.1.2
TRANSFECTION TECHNOLOGIES
 
 
 
 
 
6.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
EXTRACTION TECHNOLOGIES
 
 
 
 
 
6.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.3.1
HIGH-THROUGHPUT TECHNOLOGIES
 
 
 
 
 
 
6.3.2
COMPUTATION PROTEIN DESIGNING
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.5.1
TOP APPLICANTS/OWNERS (COMPANIES) FOR PROTEIN EXPRESSION PATENTS, 2015–2025
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
 
 
6.7.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEIN EXPRESSION MARKET
 
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
Navigate complex regulations to leverage sustainability for competitive advantage globally.
 
 
 
 
 
117
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
REGULATORY FRAMEWORK
 
 
 
 
 
 
7.1.3
INDUSTRY STANDARDS
 
 
 
 
 
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
 
7.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock hidden opportunities by understanding key buying criteria and overcoming adoption barriers.
 
 
 
 
 
125
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
9
PROTEIN EXPRESSION MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 203 Data Tables
 
 
 
 
 
130
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PRODUCTS
 
 
 
 
 
 
 
9.2.1
REAGENTS
 
 
 
 
 
 
 
9.2.1.1
CULTURE MEDIA & SUPPLEMENTS
 
 
 
 
 
 
 
 
9.2.1.1.1
OPTIMIZED AND GMP-READY MEDIA FORMULATIONS TO SUPPORT SCALABLE PROTEIN EXPRESSION
 
 
 
 
9.2.1.2
EXPRESSION VECTORS & PLASMIDS
 
 
 
 
 
 
 
 
9.2.1.2.1
GROWING PRODUCTION OF COMPLEX PROTEINS TO PROPEL MARKET
 
 
 
 
9.2.1.3
TRANSDUCTION & TRANSFECTION REAGENTS
 
 
 
 
 
 
 
 
9.2.1.3.1
HIGH-EFFICIENCY GENE DELIVERY REAGENTS TO IMPROVE TRANSIENT AND STABLE PROTEIN EXPRESSION
 
 
 
 
9.2.1.4
COMPETENT CELLS
 
 
 
 
 
 
 
 
9.2.1.4.1
INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO EXPEDITE GROWTH
 
 
 
 
9.2.1.5
OTHER REAGENTS
 
 
 
 
 
9.2.2
INSTRUMENTS
 
 
 
 
 
 
 
9.2.2.1
BIOREACTORS & FERMENTERS
 
 
 
 
 
 
 
 
9.2.2.1.1
RISING BIOLOGICS RESEARCH TO DRIVE ADOPTION OF ADVANCED BIOREACTOR SYSTEMS
 
 
 
 
9.2.2.2
CHROMATOGRAPHY SYSTEMS
 
 
 
 
 
 
 
 
9.2.2.2.1
EXPANDING RECOMBINANT PROTEIN AND ANTIBODY RESEARCH ACCELERATES DEMAND FOR AUTOMATED LAB-SCALE SYSTEMS
 
 
 
 
9.2.2.3
ANALYTICAL INSTRUMENTS
 
 
 
 
 
 
 
 
9.2.2.3.1
RISING NEED FOR RAPID PROTEIN QUALITY ASSESSMENT AND CHARACTERIZATION DRIVES DEMAND FOR ANALYTICAL INSTRUMENTS
 
 
 
 
9.2.2.4
LIQUID HANDLING & AUTOMATED SYSTEMS
 
 
 
 
 
 
 
 
9.2.2.4.1
HIGH-THROUGHPUT EXPRESSION SCREENING AND WORKFLOW MINIATURIZATION TO PROPEL ADOPTION
 
 
 
 
9.2.2.5
FILTRATION SYSTEMS
 
 
 
 
 
 
 
 
9.2.2.5.1
GROWING NEED FOR RAPID AND SCALABLE POST-EXPRESSION PROCESSING DRIVING GLOBAL ADOPTION
 
 
 
 
9.2.2.6
OTHER INSTRUMENTS
 
 
 
 
 
9.2.3
CONSUMABLES
 
 
 
 
 
 
 
9.2.3.1
CHROMATOGRAPHY & PURIFICATION CONSUMABLES
 
 
 
 
 
 
 
 
9.2.3.1.1
INCREASING NEED FOR HIGH-PURITY RECOMBINANT PROTEINS IS ACCELERATING ADOPTION
 
 
 
 
9.2.3.2
FILTRATION & SEPARATION CONSUMABLES
 
 
 
 
 
 
 
 
9.2.3.2.1
RISING DEMAND FOR RAPID, SMALL-SCALE PROTEIN PROCESSING WORKFLOWS IS DRIVING GROWTH
 
 
 
 
9.2.3.3
OTHER CONSUMABLES
 
 
 
 
 
9.2.4
KITS
 
 
 
 
 
 
 
9.2.4.1
EXPRESSION KITS
 
 
 
 
 
 
 
 
9.2.4.1.1
STANDARDIZED, HIGH-THROUGHPUT EXPRESSION KITS ACCELERATE RECOMBINANT PROTEIN DISCOVERY AND WORKFLOW REPRODUCIBILITY
 
 
 
 
9.2.4.2
CLONING & MUTAGENESIS KITS
 
 
 
 
 
 
 
 
9.2.4.2.1
RAPID CONSTRUCT ENGINEERING KITS TO ACCELERATE EXPRESSION-READY CLONE DEVELOPMENT
 
 
 
 
9.2.4.3
OTHER KITS
 
 
 
 
 
9.2.5
SOFTWARE
 
 
 
 
 
 
 
9.2.5.1
AI-ENABLED DESIGN, CODON OPTIMIZATION, AND WORKFLOW INFORMATICS DRIVE SOFTWARE ADOPTION
 
 
 
 
9.3
SERVICES
 
 
 
 
 
 
 
9.3.1
CUSTOM PROTEIN EXPRESSION SERVICES
 
 
 
 
 
 
 
9.3.1.1
RISING DEMAND FOR SPECIALIZED RECOMBINANT PROTEIN PRODUCTION SUPPORTS EXPANSION OF CUSTOM SERVICES
 
 
 
 
 
9.3.2
GENE SYNTHESIS & CLONING SERVICES
 
 
 
 
 
 
 
9.3.2.1
REDUCED WORKLOAD, IMPROVED ACCURACY, OPTIMIZED WORKFLOWS TO DRIVE DEMAND
 
 
 
 
 
9.3.3
CELL LINE DEVELOPMENT (CLD) SERVICES
 
 
 
 
 
 
 
9.3.3.1
OUTSOURCING OF HIGH-YIELD MAMMALIAN CELL LINE DEVELOPMENT DRIVES GROWTH
 
 
 
 
 
9.3.4
PROCESS DEVELOPMENT & SCALE-UP SERVICES
 
 
 
 
 
 
 
9.3.4.1
RISING NEED TO TRANSLATE EXPRESSION HITS INTO SCALABLE PRECLINICAL PROTEIN PRODUCTION SUPPORTS DEMAND GROWTH
 
 
 
10
PROTEIN EXPRESSION MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 139 Data Tables
 
 
 
 
 
220
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
MAMMALIAN CELL EXPRESSION SYSTEMS
 
 
 
 
 
 
 
10.2.1
CHINESE HAMSTER OVARY (CHO) CELL SYSTEMS
 
 
 
 
 
 
 
10.2.1.1
HIGH VIABILITY, RAPID GROWTH, AND IMPROVED EXPRESSION LEVELS TO SUPPORT GROWTH
 
 
 
 
 
10.2.2
HUMAN EMBRYONIC KIDNEY (HEK 293) CELL SYSTEMS
 
 
 
 
 
 
 
10.2.2.1
WIDE USAGE IN TRANSIENT TRANSFECTION STUDIES TO AUGMENT GROWTH
 
 
 
 
 
10.2.3
OTHER MAMMALIAN CELL EXPRESSION SYSTEMS
 
 
 
 
 
10.3
PROKARYOTIC EXPRESSION SYSTEMS
 
 
 
 
 
 
 
10.3.1
ESCHERICHIA COLI SYSTEMS
 
 
 
 
 
 
 
10.3.1.1
INCREASING USE OF E. COLI SYSTEMS FOR COMMERCIAL PROTEIN PRODUCTION TO SUPPORT MARKET
 
 
 
 
 
10.3.2
BACILLUS SYSTEMS
 
 
 
 
 
 
 
10.3.2.1
EFFICIENT SECRETION CAPABILITIES DRIVE GROWING ADOPTION
 
 
 
 
 
10.3.3
OTHER PROKARYOTIC EXPRESSION SYSTEMS
 
 
 
 
 
10.4
INSECT CELL EXPRESSION SYSTEMS
 
 
 
 
 
 
 
10.4.1
BACULOVIRUS SYSTEMS
 
 
 
 
 
 
 
10.4.1.1
HIGH PROTEIN YIELD AND EXPRESSION LEVELS OF INTRACELLULAR PROTEINS THROUGH THE BACULOVIRUS EXPRESSION SYSTEM TO SUPPORT GROWTH
 
 
 
 
 
10.4.2
OTHER INSECT CELL SYSTEMS
 
 
 
 
 
10.5
YEAST EXPRESSION SYSTEMS
 
 
 
 
 
 
 
10.5.1
PICHIA SYSTEMS
 
 
 
 
 
 
 
10.5.1.1
HIGH SCALABILITY AND EFFICIENT PROTEIN PRODUCTION TO SUPPORT GROWTH
 
 
 
 
 
10.5.2
SACCHAROMYCES SYSTEMS
 
 
 
 
 
 
 
10.5.2.1
EFFICIENT SECRETORY PATHWAYS AND SCALABLE RECOMBINANT PROTEIN PRODUCTION TO SUPPORT MARKET GROWTH
 
 
 
 
 
10.5.3
OTHER YEAST EXPRESSION SYSTEMS
 
 
 
 
 
10.6
CELL-FREE EXPRESSION SYSTEMS
 
 
 
 
 
 
 
10.6.1
E. COLI LYSATE-BASED SYSTEMS
 
 
 
 
 
 
 
10.6.1.1
RAPID AND FLEXIBLE PLATFORMS FOR PROTEIN SYNTHESIS TO DRIVE ADOPTION
 
 
 
 
 
10.6.2
OTHER CELL-FREE EXPRESSION SYSTEMS
 
 
 
 
 
10.7
ALGAL & PLANT-BASED EXPRESSION SYSTEMS
 
 
 
 
 
 
 
10.7.1
GROWTH IN VACCINES MARKET TO SUPPORT SEGMENT
 
 
 
 
11
PROTEIN EXPRESSION MARKET, BY WORKFLOW
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
286
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
CLONING & TRANSFECTION
 
 
 
 
 
 
 
11.2.1
CONTINUOUS REPLENISHMENT OF CONSUMABLES AND REAGENTS TO SUPPORT THE MARKET
 
 
 
 
 
11.3
TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION (PTM)
 
 
 
 
 
 
 
11.3.1
GROWING NEED FOR FUNCTIONAL AND STABLE PROTEINS TO DRIVE MARKET
 
 
 
 
 
11.4
EXTRACTION, PURIFICATION, AND CHARACTERIZATION
 
 
 
 
 
 
 
11.4.1
NEED TO ADHERE TO REQUIRED STANDARDS FOR SUITABLE APPLICATIONS TO DRIVE MARKET
 
 
 
 
12
PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
298
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
DISCOVERY & RESEARCH SCALE
 
 
 
 
 
 
 
12.2.1
EXPANDING BIOLOGICS PIPELINE AND FOCUS ON COMPUTATIONALLY DESIGNED PROTEINS TO AID GROWTH
 
 
 
 
 
12.3
PRECLINICAL & CHARACTERIZATION SCALE
 
 
 
 
 
 
 
12.3.1
SIGNIFICANT NUMBER OF BIOLOGIC CANDIDATES ENTERING PRE-CLINICAL DEVELOPMENT TO BOOST THE MARKET
 
 
 
 
 
12.4
PROCESS DEVELOPMENT & PILOT SCALE
 
 
 
 
 
 
 
12.4.1
INCREASING OUTSOURCING OF EXPRESSION AT PROCESS DEVELOPMENT SCALE TO SUPPORT GROWTH
 
 
 
 
13
PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 36 Data Tables
 
 
 
 
 
310
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
MONOCLONAL ANTIBODIES & DERIVATIVES
 
 
 
 
 
 
 
13.2.1
EXPANDING ANTIBODY DISCOVERY, BISPECIFIC DEVELOPMENT, AND MAMMALIAN EXPRESSION OPTIMIZATION DRIVE DEMAND
 
 
 
 
 
13.3
RECOMBINANT THERAPEUTIC PROTEINS
 
 
 
 
 
 
 
13.3.1
INCREASING DEVELOPMENT OF RECOMBINANT BIOLOGICS AND ENGINEERED THERAPEUTIC PROTEINS IS DRIVING DEMAND
 
 
 
 
 
13.4
VACCINES
 
 
 
 
 
 
 
13.4.1
RISING DEMAND FOR RECOMBINANT ANTIGENS AND NEXT-GENERATION VACCINE PLATFORMS DRIVES PROTEIN EXPRESSION ADOPTION IN VACCINE RESEARCH
 
 
 
 
 
13.5
ENZYMES & CATALYTIC PROTEINS
 
 
 
 
 
 
 
13.5.1
EXPANDING ENZYME ENGINEERING AND BIOCATALYSIS APPLICATIONS ARE ACCELERATING DEMAND
 
 
 
 
 
13.6
OTHER PROTEINS
 
 
 
 
 
14
PROTEIN EXPRESSION MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 30 Data Tables
 
 
 
 
 
328
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
THERAPEUTIC APPLICATIONS
 
 
 
 
 
 
 
14.2.1
RISING DEMAND FOR BIOLOGICS THERAPIES TO FACILITATE GROWTH
 
 
 
 
 
14.3
RESEARCH APPLICATIONS
 
 
 
 
 
 
 
14.3.1
GROWING INTEREST IN PROTEOMICS, GENOMICS, AND DRUG DISCOVERY TO BOOST MARKET
 
 
 
 
 
14.4
INDUSTRIAL APPLICATIONS
 
 
 
 
 
 
 
14.4.1
INCREASING USE OF PROTEINS IN COSMETICS, TEXTILES, AND INDUSTRIAL ENZYMES TO PROMOTE GROWTH
 
 
 
 
 
14.5
DIAGNOSTIC APPLICATIONS
 
 
 
 
 
 
 
14.5.1
RECOMBINANT PROTEINS AND ASSAY-READY REAGENTS TO STRENGTHEN DIAGNOSTIC DEVELOPMENT
 
 
 
 
15
PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
345
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
15.2.1
RISING INVESTMENT IN BIOLOGICS AND INCREASING APPROVALS FOR BIOLOGICS TO SUPPORT GROWTH
 
 
 
 
 
15.3
CROS & CDMOS
 
 
 
 
 
 
 
15.3.1
INCREASE IN OUTSOURCING AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING TO BOOST MARKET
 
 
 
 
 
15.4
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
15.4.1
INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET
 
 
 
 
 
15.5
OTHER END USERS
 
 
 
 
 
16
PROTEIN EXPRESSION SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
361
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
16.2.1
INCREASING SHIFT TOWARD DRUG DEVELOPMENT OUTSOURCING TO FAVOR GROWTH
 
 
 
 
 
16.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
16.3.1
RISING PARTNERSHIPS BETWEEN ACADEMIA AND CONTRACT RESEARCH ORGANIZATIONS TO AID GROWTH
 
 
 
 
 
16.4
OTHER END USERS
 
 
 
 
 
17
PROTEIN EXPRESSION MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 19 Countries | 577 Data Tables.
 
 
 
 
 
373
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
NORTH AMERICA
 
 
 
 
 
 
 
17.2.1
US
 
 
 
 
 
 
 
17.2.1.1
GROWING FOCUS ON DEVELOPING NEW THERAPEUTICS AND PROTEIN-BASED DRUGS TO DRIVE MARKET
 
 
 
 
 
17.2.2
CANADA
 
 
 
 
 
 
 
17.2.2.1
INCREASING INCIDENCE OF CANCER AND PREVALENCE OF PUBLIC-PRIVATE PARTNERSHIPS TO SUSTAIN GROWTH
 
 
 
 
17.3
EUROPE
 
 
 
 
 
 
 
17.3.1
GERMANY
 
 
 
 
 
 
 
17.3.1.1
INCREASING PROTEOMICS-BASED RESEARCH AND HEALTHCARE INVESTMENTS TO PROMOTE GROWTH
 
 
 
 
 
17.3.2
UK
 
 
 
 
 
 
 
17.3.2.1
GROWING DEVELOPMENT OF IMMUNOTHERAPIES, VACCINES, AND PROTEOMICS TO FUEL MARKET
 
 
 
 
 
17.3.3
FRANCE
 
 
 
 
 
 
 
17.3.3.1
RISE IN FUNDING FOR PROTEOMICS AND GENOMICS TO SPUR GROWTH
 
 
 
 
 
17.3.4
ITALY
 
 
 
 
 
 
 
17.3.4.1
GROWING LIFE SCIENCE RESEARCH SUPPORTED BY UNIVERSITIES AND RESEARCH INSTITUTIONS TO BOOST MARKET
 
 
 
 
 
17.3.5
SPAIN
 
 
 
 
 
 
 
17.3.5.1
GROWING EXPANSION OF BIOTECH COMPANIES AND INCREASING R&D EXPENDITURE TO DRIVE MARKET
 
 
 
 
 
17.3.6
NETHERLANDS
 
 
 
 
 
 
 
17.3.6.1
PRESENCE OF ADVANCED INFRASTRUCTURE TO FUEL MARKET
 
 
 
 
 
17.3.7
REST OF EUROPE
 
 
 
 
 
17.4
ASIA PACIFIC
 
 
 
 
 
 
 
17.4.1
CHINA
 
 
 
 
 
 
 
17.4.1.1
RISING BIOLOGICS DEVELOPMENT DRIVING MARKET GROWTH
 
 
 
 
 
17.4.2
JAPAN
 
 
 
 
 
 
 
17.4.2.1
GROWING GOVERNMENT INITIATIVES AND EXPANSION OF BIOPHARMA COMPANIES TO BOOST MARKET
 
 
 
 
 
17.4.3
INDIA
 
 
 
 
 
 
 
17.4.3.1
RISING COLLABORATIONS BETWEEN PRIVATE SECTOR AND ACADEMIA TO FACILITATE GROWTH
 
 
 
 
 
17.4.4
AUSTRALIA
 
 
 
 
 
 
 
17.4.4.1
STRONG REGULATORY FRAMEWORK, CLINICAL INNOVATION, AND GLOBAL PARTNERSHIPS DRIVE MARKET GROWTH
 
 
 
 
 
17.4.5
SOUTH KOREA
 
 
 
 
 
 
 
17.4.5.1
INCREASING RESEARCH & DEVELOPMENT OF NOVEL THERAPIES TO FACILITATE GROWTH
 
 
 
 
 
17.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
17.5
LATIN AMERICA
 
 
 
 
 
 
 
17.5.1
BRAZIL
 
 
 
 
 
 
 
17.5.1.1
GROWING INDUSTRIAL INVESTMENTS TO PROPEL MARKET
 
 
 
 
 
17.5.2
MEXICO
 
 
 
 
 
 
 
17.5.2.1
INCREASING GOVERNMENT SUPPORT FOR BIOPHARMACEUTICAL PRODUCTION TO DRIVE MARKET
 
 
 
 
 
17.5.3
ARGENTINA
 
 
 
 
 
 
 
17.5.3.1
RISE IN BIOTECHNOLOGY AND PHARMACEUTICAL RESEARCH & DEVELOPMENT TO AUGMENT GROWTH
 
 
 
 
 
17.5.4
REST OF LATIN AMERICA
 
 
 
 
 
17.6
MIDDLE EAST
 
 
 
 
 
 
 
17.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
17.6.1.1
SAUDI ARABIA
 
 
 
 
 
 
 
 
17.6.1.1.1
RISING DEMAND FOR BIOLOGICS AND INCREASING HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
 
 
 
 
17.6.1.2
UNITED ARAB EMIRATES
 
 
 
 
 
 
 
 
17.6.1.2.1
DEVELOPING BIOPHARMA SECTOR TO DRIVE MARKET
 
 
 
 
17.6.1.3
REST OF GCC COUNTRIES
 
 
 
 
 
17.6.2
REST OF MIDDLE EAST
 
 
 
 
 
17.7
AFRICA
 
 
 
 
 
18
COMPETITIVE LANDSCAPE
Discover key strategies and market positions shaping the protein expression competitive landscape.
 
 
 
 
 
625
 
18.1
OVERVIEW
 
 
 
 
 
 
18.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
18.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PROTEIN EXPRESSION MARKET
 
 
 
 
 
18.3
REVENUE ANALYSIS
 
 
 
 
 
 
 
18.4
MARKET SHARE ANALYSIS
 
 
 
 
 
 
 
18.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
18.5.1
STARS
 
 
 
 
 
 
18.5.2
EMERGING LEADERS
 
 
 
 
 
 
18.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
18.5.4
PARTICIPANTS
 
 
 
 
 
 
18.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
18.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
18.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
18.5.5.3
OFFERING FOOTPRINT
 
 
 
 
 
 
18.5.5.4
TYPE FOOTPRINT
 
 
 
 
 
 
18.5.5.5
APPLICATION FOOTPRINT
 
 
 
 
18.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
18.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
18.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
18.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
18.6.4
STARTING BLOCKS
 
 
 
 
 
 
18.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
18.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
18.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
18.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
 
18.7.1
COMPANY VALUATION
 
 
 
 
 
 
18.7.2
FINANCIAL METRICS
 
 
 
 
 
18.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
18.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
18.9.1
PRODUCT & SERVICE LAUNCHES
 
 
 
 
 
 
18.9.2
DEALS
 
 
 
 
 
 
18.9.3
EXPANSIONS
 
 
 
 
19
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
647
 
19.1
MAJOR PLAYERS
 
 
 
 
 
 
 
19.1.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
 
19.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
19.1.1.2
PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
19.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
19.1.1.3.1
PRODUCT & SERVICE LAUNCHES
 
 
 
 
 
 
19.1.1.3.2
DEALS
 
 
 
 
 
 
19.1.1.3.3
EXPANSIONS
 
 
 
 
19.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
19.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
19.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
19.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
19.1.2
MERCK KGAA
 
 
 
 
 
 
19.1.3
DANAHER CORPORATION
 
 
 
 
 
 
19.1.4
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
19.1.5
SARTORIUS AG
 
 
 
 
 
 
19.1.6
GENSCRIPT
 
 
 
 
 
 
19.1.7
TAKARA BIO INC.
 
 
 
 
 
 
19.1.8
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
 
19.1.9
QIAGEN
 
 
 
 
 
 
19.1.10
CHARLES RIVER LABORATORIES
 
 
 
 
 
 
19.1.11
CORNING INCORPORATED
 
 
 
 
 
 
19.1.12
LONZA
 
 
 
 
 
 
19.1.13
FUJIFILM HOLDINGS CORPORATION
 
 
 
 
 
 
19.1.14
SYNGENE INTERNATIONAL LIMITED
 
 
 
 
 
 
19.1.15
LGC LIMITED
 
 
 
 
 
 
19.1.16
EUROFINS SCIENTIFIC
 
 
 
 
 
 
19.1.17
AJINOMOTO CO., INC.
 
 
 
 
 
19.2
OTHER PLAYERS
 
 
 
 
 
 
 
19.2.1
PROMEGA CORPORATION
 
 
 
 
 
 
19.2.2
SINO BIOLOGICAL, INC.
 
 
 
 
 
 
19.2.3
RAYBIOTECH, INC.
 
 
 
 
 
 
19.2.4
BIONEER CORPORATION
 
 
 
 
 
 
19.2.5
ORIGENE TECHNOLOGIES, INC.
 
 
 
 
 
 
19.2.6
NEW ENGLAND BIOLABS
 
 
 
 
 
 
19.2.7
ACCURUS BIOSCIENCES
 
 
 
 
 
 
19.2.8
ARAGEN LIFE SCIENCES LTD.
 
 
 
 
 
 
19.2.9
OXFORD EXPRESSION TECHNOLOGIES LTD
 
 
 
 
 
 
19.2.10
PROTEOGENIX INC.
 
 
 
 
 
 
19.2.11
ABEOMICS
 
 
 
 
20
RESEARCH METHODOLOGY
 
 
 
 
 
729
 
20.1
RESEARCH DATA
 
 
 
 
 
 
 
20.1.1
SECONDARY DATA
 
 
 
 
 
 
20.1.2
PRIMARY DATA
 
 
 
 
 
20.2
MARKET ESTIMATION METHODOLOGY
 
 
 
 
 
 
 
20.2.1
MARKET SIZE ESTIMATION
 
 
 
 
 
 
20.2.2
INSIGHTS OF PRIMARY EXPERTS
 
 
 
 
 
 
20.2.3
TOP-DOWN APPROACH
 
 
 
 
 
20.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
 
20.4
MARKET BREAKDOWN AND DATA TRIANGULATION
 
 
 
 
 
 
20.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
20.6
RESEARCH LIMITATIONS
 
 
 
 
 
 
20.7
RISK ANALYSIS
 
 
 
 
 
21
APPENDIX
 
 
 
 
 
741
 
21.1
DISCUSSION GUIDE
 
 
 
 
 
 
21.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
21.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
21.4
RELATED REPORTS
 
 
 
 
 
 
21.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
PROTEIN EXPRESSION MARKET: IMPACT ANALYSIS
 
 
 
 
 
 
TABLE 2
PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 3
PROTEIN EXPRESSION MARKET: ROLE IN ECOSYSTEM
 
 
 
 
 
 
TABLE 4
AVERAGE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY KEY PLAYER, 2023-2025 (USD)
 
 
 
 
 
 
TABLE 5
INDICATIVE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY REGION, 2025 (USD)
 
 
 
 
 
 
TABLE 6
IMPORT DATA FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022–2023 (USD THOUSAND)
 
 
 
 
 
 
TABLE 7
IMPORT VOLUME FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022–2025, (UNIT/TONS)
 
 
 
 
 
 
TABLE 8
EXPORT DATA FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022–2025, (USD THOUSAND)
 
 
 
 
 
 
TABLE 9
EXPORT VOLUME FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022–2025, (UNIT/TONS)
 
 
 
 
 
 
TABLE 10
PROTEIN EXPRESSION MARKET: KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 11
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 12
INDICATIVE LIST OF PATENTS IN PROTEIN EXPRESSION MARKET, 2024
 
 
 
 
 
 
TABLE 13
CASE STUDIES OF AI IMPLEMENTATION IN PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
TABLE 14
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 19
COUNTRY-WISE REGULATORY SCENARIO FOR PROTEIN EXPRESSION PRODUCT & SERVICE PROVIDERS
 
 
 
 
 
 
TABLE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
 
 
 
 
 
 
TABLE 21
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
TABLE 22
PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 23
PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 24
PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 25
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 26
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 27
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
NORTH AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
CULTURE MEDIA & SUPPLEMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
NORTH AMERICA: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
EUROPE: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
ASIA PACIFIC: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
LATIN AMERICA: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
MIDDLE EAST: CULTURE MEDIA & SUPPLEMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
GCC COUNTRIES: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
EXPRESSION VECTORS & PLASMIDS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
NORTH AMERICA: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
EUROPE: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
ASIA PACIFIC: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
LATIN AMERICA: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
MIDDLE EAST: EXPRESSION VECTORS & PLASMIDS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
GCC COUNTRIES: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
NORTH AMERICA: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
EUROPE: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
ASIA PACIFIC: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
LATIN AMERICA: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
MIDDLE EAST: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
GCC COUNTRIES: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
COMPETENT CELLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
NORTH AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
EUROPE: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
ASIA PACIFIC: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
LATIN AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
MIDDLE EAST: COMPETENT CELLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
GCC COUNTRIES: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
NORTH AMERICA: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
EUROPE: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
ASIA PACIFIC: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
LATIN AMERICA: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
MIDDLE EAST: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
GCC COUNTRIES: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
NORTH AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
EUROPE: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
ANALYTICAL INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
MIDDLE EAST: ANALYTICAL INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
NORTH AMERICA: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
EUROPE: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
ASIA PACIFIC: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
LATIN AMERICA: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
MIDDLE EAST: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
GCC COUNTRIES: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
FILTRATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
NORTH AMERICA: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
EUROPE: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
ASIA PACIFIC: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
LATIN AMERICA: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
MIDDLE EAST: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
GCC COUNTRIES: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
NORTH AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
NORTH AMERICA: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
EUROPE: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
ASIA PACIFIC: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
LATIN AMERICA: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
MIDDLE EAST: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
GCC COUNTRIES: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
FILTRATION & SEPARATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
NORTH AMERICA: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
EUROPE: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
ASIA PACIFIC: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
LATIN AMERICA: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
MIDDLE EAST: FILTRATION & SEPARATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
GCC COUNTRIES: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
NORTH AMERICA: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
EUROPE: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
ASIA PACIFIC: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
LATIN AMERICA: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
MIDDLE EAST: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
GCC COUNTRIES: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
NORTH AMERICA: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
EUROPE: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
NORTH AMERICA: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
EUROPE: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
ASIA PACIFIC: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
LATIN AMERICA: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
MIDDLE EAST: EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
GCC COUNTRIES: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
CLONING & MUTAGENESIS KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
NORTH AMERICA: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
EUROPE: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
ASIA PACIFIC: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
LATIN AMERICA: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
MIDDLE EAST: CLONING & MUTAGENESIS KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
GCC COUNTRIES: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
OTHER PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
NORTH AMERICA: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
EUROPE: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
ASIA PACIFIC: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
LATIN AMERICA: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
MIDDLE EAST: OTHER PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
GCC COUNTRIES: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
PROTEIN EXPRESSION SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
NORTH AMERICA: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
EUROPE: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
ASIA PACIFIC: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
LATIN AMERICA: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
MIDDLE EAST: PROTEIN EXPRESSION SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
GCC COUNTRIES: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
NORTH AMERICA: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
EUROPE: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
ASIA PACIFIC: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
LATIN AMERICA: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
MIDDLE EAST: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
GCC COUNTRIES: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
GENE SYNTHESIS & CLONING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
NORTH AMERICA: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
EUROPE: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
ASIA PACIFIC: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
LATIN AMERICA: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
MIDDLE EAST: GENE SYNTHESIS & CLONING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
GCC COUNTRIES: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
CELL LINE DEVELOPMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
NORTH AMERICA: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
EUROPE: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
ASIA PACIFIC: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
LATIN AMERICA: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
MIDDLE EAST: CELL LINE DEVELOPMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
GCC COUNTRIES: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
NORTH AMERICA: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
EUROPE: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
ASIA PACIFIC: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
LATIN AMERICA: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
MIDDLE EAST: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
GCC COUNTRIES: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
EUROPE: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
EUROPE: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
EUROPE: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
GCC COUNTRIES: PROTEIN EXPRESSION MARKET PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION REGION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
GCC COUNTRIES: PROTEIN EXPRESSION MARKET E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
MIDDLE EAST: PROTEIN EXPRESSION MARKET OTHER CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
EUROPE: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
EUROPE: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
EUROPE: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
MIDDLE EAST: PROTEIN PRODUCTS EXPRESSION MARKET FOR DISCOVERY & RESEARCH SCALE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
GCC COUNTRIES: PROTEIN PRODUCTS EXPRESSION MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
EUROPE: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
LIST OF INDUSTRIAL ENZYMES AND APPLICATIONS
 
 
 
 
 
 
TABLE 460
PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
EUROPE: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
PROTEIN EXPRESSION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
NORTH AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
NORTH AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
NORTH AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
NORTH AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 546
US: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 547
US: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 548
US: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 549
US: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 550
US: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 551
US: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 552
US: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 553
US: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 554
US: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 555
US: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 556
US: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 557
US: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 558
US: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 559
US: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 560
US: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 561
US: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 562
US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 563
US: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 564
US: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 565
CANADA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 566
CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 567
CANADA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 568
CANADA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 569
CANADA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 570
CANADA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 571
CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 572
CANADA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 573
CANADA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 574
CANADA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 575
CANADA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 576
CANADA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 577
CANADA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 578
CANADA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 579
CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 580
CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 581
CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 582
CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 583
CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 584
EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 585
EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 586
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 587
EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 588
EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 589
EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 590
EUROPE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 591
EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 592
EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 593
EUROPE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 594
EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 595
EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 596
EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 597
EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 598
EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 599
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 600
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 601
EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 602
EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 603
EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 604
GERMANY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 605
GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 606
GERMANY: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 607
GERMANY: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 608
GERMANY: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 609
GERMANY: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 610
GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 611
GERMANY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 612
GERMANY: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 613
GERMANY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 614
GERMANY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 615
GERMANY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 616
GERMANY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 617
GERMANY: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 618
GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 619
GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 620
GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 621
GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 622
GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 623
UK: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 624
UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 625
UK: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 626
UK: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 627
UK: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 628
UK: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 629
UK: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 630
UK: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 631
UK: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 632
UK: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 633
UK: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 634
UK: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 635
UK: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 636
UK: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 637
UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 638
UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 639
UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 640
UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 641
UK: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 642
FRANCE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 643
FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 644
FRANCE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 645
FRANCE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 646
FRANCE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 647
FRANCE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 648
FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 649
FRANCE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 650
FRANCE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 651
FRANCE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 652
FRANCE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 653
FRANCE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 654
FRANCE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 655
FRANCE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 656
FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 657
FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 658
FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 659
FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 660
FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 661
ITALY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 662
ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 663
ITALY: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 664
ITALY: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 665
ITALY: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 666
ITALY: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 667
ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 668
ITALY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 669
ITALY: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 670
ITALY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 671
ITALY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 672
ITALY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 673
ITALY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 674
ITALY: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 675
ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 676
ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 677
ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 678
ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 679
ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 680
SPAIN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 681
SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 682
SPAIN: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 683
SPAIN: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 684
SPAIN: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 685
SPAIN: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 686
SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 687
SPAIN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 688
SPAIN: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 689
SPAIN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 690
SPAIN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 691
SPAIN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 692
SPAIN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 693
SPAIN: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 694
SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 695
SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 696
SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 697
SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 698
SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 699
NETHERLANDS: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 700
NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 701
NETHERLANDS: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 702
NETHERLANDS: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 703
NETHERLANDS: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 704
NETHERLANDS: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 705
NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 706
NETHERLANDS: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 707
NETHERLANDS: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 708
NETHERLANDS: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 709
NETHERLANDS: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 710
NETHERLANDS: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 711
NETHERLANDS: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 712
NETHERLANDS: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 713
NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 714
NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 715
NETHERLANDS: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 716
NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 717
NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 718
REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 719
REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 720
REST OF EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 721
REST OF EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 722
REST OF EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 723
REST OF EUROPE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 724
REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 725
REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 726
REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 727
REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 728
REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 729
REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 730
REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 731
REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 732
REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 733
REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 734
REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 735
REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 736
REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 737
ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 738
ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 739
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 740
ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 741
ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 742
ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 743
ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 744
ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 745
ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 746
ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 747
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 748
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 749
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 750
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 751
ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 752
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 753
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 754
ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 755
ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 756
ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 757
CHINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 758
CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 759
CHINA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 760
CHINA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 761
CHINA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 762
CHINA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 763
CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 764
CHINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 765
CHINA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 766
CHINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 767
CHINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 768
CHINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 769
CHINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 770
CHINA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 771
CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 772
CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 773
CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 774
CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 775
CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 776
JAPAN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 777
JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 778
JAPAN: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 779
JAPAN: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 780
JAPAN: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 781
JAPAN: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 782
JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 783
JAPAN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 784
JAPAN: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 785
JAPAN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 786
JAPAN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 787
JAPAN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 788
JAPAN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 789
JAPAN: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 790
JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 791
JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 792
JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 793
JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 794
JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 795
INDIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 796
INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 797
INDIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 798
INDIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 799
INDIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 800
INDIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 801
INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 802
INDIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 803
INDIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 804
INDIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 805
INDIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 806
INDIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 807
INDIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 808
INDIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 809
INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 810
INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 811
INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 812
INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 813
INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 814
AUSTRALIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 815
AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 816
AUSTRALIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 817
AUSTRALIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 818
AUSTRALIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 819
AUSTRALIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 820
AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 821
AUSTRALIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 822
AUSTRALIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 823
AUSTRALIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 824
AUSTRALIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 825
AUSTRALIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 826
AUSTRALIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 827
AUSTRALIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 828
AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 829
AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 830
AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 831
AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 832
AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 833
SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 834
SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 835
SOUTH KOREA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 836
SOUTH KOREA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 837
SOUTH KOREA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 838
SOUTH KOREA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 839
SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 840
SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 841
SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 842
SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 843
SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 844
SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 845
SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 846
SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 847
SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 848
SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 849
SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 850
SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 851
SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 852
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 853
REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 854
REST OF ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 855
REST OF ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 856
REST OF ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 857
REST OF ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 858
REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 859
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 860
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 861
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 862
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 863
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 864
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 865
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 866
REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 867
REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 868
REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 869
REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 870
REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 871
LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 872
LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 873
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 874
LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 875
LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 876
LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 877
LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 878
LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 879
LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 880
LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 881
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 882
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 883
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 884
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 885
LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 886
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 887
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 888
LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 889
LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 890
LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 891
BRAZIL: BRAZIL: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 892
BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 893
BRAZIL: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 894
BRAZIL: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 895
BRAZIL: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 896
BRAZIL: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 897
BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 898
BRAZIL: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 899
BRAZIL: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 900
BRAZIL: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 901
BRAZIL: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 902
BRAZIL: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 903
BRAZIL: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 904
BRAZIL: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 905
BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 906
BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 907
BRAZIL: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 908
BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 909
BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 910
MEXICO: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 911
MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 912
MEXICO: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 913
MEXICO: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 914
MEXICO: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 915
MEXICO: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 916
MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 917
MEXICO: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 918
MEXICO: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 919
MEXICO: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 920
MEXICO: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 921
MEXICO: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 922
MEXICO: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 923
MEXICO: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 924
MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 925
MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 926
MEXICO: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 927
MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 928
MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 929
ARGENTINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 930
ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 931
ARGENTINA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 932
ARGENTINA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 933
ARGENTINA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 934
ARGENTINA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 935
ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 936
ARGENTINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 937
ARGENTINA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 938
ARGENTINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 939
ARGENTINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 940
ARGENTINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 941
ARGENTINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 942
ARGENTINA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 943
ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 944
ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 945
ARGENTINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 946
ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 947
ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 948
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 949
REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 950
REST OF LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 951
REST OF LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 952
REST OF LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 953
REST OF LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 954
REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 955
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 956
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 957
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 958
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 959
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 960
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 961
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 962
REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 963
REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 964
REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 965
REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 966
REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 967
MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 968
MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 969
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 970
MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 971
MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 972
MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 973
MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 974
MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 975
MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 976
MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 977
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 978
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 979
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 980
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 981
MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 982
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 983
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 984
MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 985
MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 986
MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 987
GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 988
GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 989
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 990
GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 991
GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 992
GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 993
GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 994
GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 995
GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 996
GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 997
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 998
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 999
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1000
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1001
GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1002
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1003
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1004
GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1005
GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1006
GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1007
SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1008
SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1009
SAUDI ARABIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1010
SAUDI ARABIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1011
SAUDI ARABIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1012
SAUDI ARABIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1013
SAUDI ARABIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1014
SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1015
SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1016
SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1017
SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1018
SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1019
SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1020
SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1021
SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1022
SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1023
SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1024
SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1025
SAUDI ARABIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1026
UAE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1027
UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1028
UAE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1029
UAE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1030
UAE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1031
UAE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1032
UAE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1033
UAE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1034
UAE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1035
UAE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1036
UAE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1037
UAE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1038
UAE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1039
UAE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1040
UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1041
UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1042
UAE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1043
UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1044
UAE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1045
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1046
REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1047
REST OF GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1048
REST OF GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1049
REST OF GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1050
REST OF GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1051
REST OF GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1052
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1053
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1054
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1055
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1056
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1057
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1058
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1059
REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1060
REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1061
REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1062
REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1063
REST OF GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1064
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1065
REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1066
REST OF MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1067
REST OF MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1068
REST OF MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1069
REST OF MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1070
REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1071
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1072
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1073
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1074
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1075
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1076
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1077
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1078
REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1079
REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1080
REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1081
REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1082
REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1083
AFRICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1084
AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1085
AFRICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1086
AFRICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1087
AFRICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1088
AFRICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1089
AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1090
AFRICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1091
AFRICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1092
AFRICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1093
AFRICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1094
AFRICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1095
AFRICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1096
AFRICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1097
AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1098
AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1099
AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1100
AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1101
AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 1102
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
TABLE 1103
PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 1104
PROTEIN EXPRESSION MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 1105
PROTEIN EXPRESSION MARKET: OFFERING FOOTPRINT
 
 
 
 
 
 
TABLE 1106
PROTEIN EXPRESSION MARKET: TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 1107
PROTEIN EXPRESSION MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 1108
PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 1109
PROTEIN EXPRESSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 1110
PROTEIN EXPRESSION MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1111
PROTEIN EXPRESSION MARKET: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1112
PROTEIN EXPRESSION MARKET: EXPANSIONS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1113
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1114
THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1115
THERMO FISHER SCIENTIFIC INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1116
THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1117
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1118
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1119
MERCK KGAA: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1120
MERCK KGAA: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1121
MERCK KGAA: EXPANSIONS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1122
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1123
DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1124
DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1125
DANAHER CORPORATION: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1126
DANAHER CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1127
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1128
AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1129
AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1130
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1131
SARTORIUS AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1132
SARTORIUS AG: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1133
SARTORIUS AG: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1134
SARTORIUS AG: EXPANSIONS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1135
GENSCRIPT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1136
GENSCRIPT: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1137
GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1138
TAKARA BIO INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1139
TAKARA BIO INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1140
TAKARA BIO INC.: EXPANSIONS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1141
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1142
BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1143
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1144
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1145
QIAGEN: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1146
QIAGEN: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1147
QIAGEN: PRODUCT LAUNCHES, JANUARY 2023- APRIL 2026
 
 
 
 
 
 
TABLE 1148
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023- APRIL 2026
 
 
 
 
 
 
TABLE 1149
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1150
CHARLES RIVER LABORATORIES: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1151
CHARLES RIVER LABORATORIES: PRODUCT/SERVICE LAUNCHES, JANUARY 2023- APRIL 2026
 
 
 
 
 
 
TABLE 1152
CORNING INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1153
CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1154
CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2023- APRIL 2026
 
 
 
 
 
 
TABLE 1155
LONZA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1156
LONZA: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1157
LONZA: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1158
LONZA: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1159
FUJIFILM CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1160
FUJIFILM CORPORATION: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1161
FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1162
FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1163
SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1164
SYNGENE INTERNATIONAL LIMITED: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1165
SYNGENE INTERNATIONAL LIMITED: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 1166
LGC LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1167
LGC LIMITED: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1168
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1169
EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1170
EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023- APRIL 2026
 
 
 
 
 
 
TABLE 1171
AJINOMOTO CO., INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1172
AJINOMOTO CO., INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1173
AJINOMOTO CO., INC.: DEALS, JANUARY 2023- APRIL 2026
 
 
 
 
 
 
TABLE 1174
PROMEGA CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1175
SINO BIOLOGICAL, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1176
RAYBIOTECH, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1177
BIONEER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1178
ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1179
NEW ENGLAND BIOLABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1180
ACCURUS BIOSCIENCES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1181
ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1182
OXFORD EXPRESSION TECHNOLOGIES LTD: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1183
PROTEOGENIX INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1184
ABEOMICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1185
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 2
GLOBAL PROTEIN EXPRESSION MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 4
DISRUPTIONS INFLUENCING GROWTH OF PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
FIGURE 5
HIGH-GROWTH SEGMENTS IN PROTEIN EXPRESSION MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN THE PROTEIN EXPRESSION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 7
CONTINUOUS INNOVATION IN EXPRESSION TECHNOLOGIES TO DRIVE GROWTH IN PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
FIGURE 8
PRODUCT SEGMENT IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
 
 
 
 
 
 
FIGURE 9
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 11
PROTEIN EXPRESSION MARKET: PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 12
PROTEIN EXPRESSION PRODUCTS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 13
PROTEIN EXPRESSION SERVICES MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 14
PROTEIN EXPRESSION MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 15
AVERAGE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY KEY PLAYER
 
 
 
 
 
 
FIGURE 16
INDICATIVE SELLING PRICE TREND OF PROTEIN EXPRESSION SYSTEMS, BY REGION, 2025 (USD)
 
 
 
 
 
 
FIGURE 17
PROTEIN EXPRESSION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 18
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
 
 
 
 
 
 
FIGURE 19
TOP APPLICANTS/OWNERS (COMPANIES) FOR PROTEIN EXPRESSION PATENTS, 2015–2025
 
 
 
 
 
 
FIGURE 20
IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET
 
 
 
 
 
 
FIGURE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
FIGURE 22
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
FIGURE 23
NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 24
ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 25
REVENUE ANALYSIS OF KEY PLAYERS, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 26
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 27
PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 28
PROTEIN EXPRESSION MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 29
PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 30
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 31
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 32
PROTEIN EXPRESSION MARKET: BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
FIGURE 33
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 34
MERCK KGAA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 35
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 36
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 37
SARTORIUS AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 38
GENSCRIPT: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 39
TAKARA BIO INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
QIAGEN: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
CORNING INCORPORATED: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 44
LONZA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 46
SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 47
LGC LIMITED: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 48
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 49
AJINOMOTO CO., INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 50
RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 51
PROTEIN EXPRESSION MARKET: BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
FIGURE 52
PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
 
 
 
 
 
 
FIGURE 53
MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025
 
 
 
 
 
 
FIGURE 54
REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC. (2025)
 
 
 
 
 
 
FIGURE 55
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 56
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 57
PROTEIN EXPRESSION MARKET CAGR PROJECTIONS:
 
 
 
 
 
 
FIGURE 58
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

 

Methodology

This study involved four major activities in estimating the current size of the protein expression market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, the data triangulation procedure was used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was primarily used to identify and gather information for the extensive, technical, market-oriented, and commercial study. The secondary sources referred for this research study include publications from government sources, such as the National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Health Organization (WHO), Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceutical Research and Manufacturers of America (PhRMA), Global Cancer Observatory (GLOBOCAN), Centers for Disease Control and Prevention (CDC), and European Federation of Biotechnology,. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global protein expression market, and the findings were validated through primary research.

Primary Research

In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Protein Expression Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the protein expression market was estimated through multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Protein Expression Market : Top-Down and Bottom-Up Approach

Protein Expression Market Top Down and Bottom Up Approach

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.

Market Definition

The protein expression market encompasses the technologies, products, and services required for protein production and analysis. This market includes various expression systems (mammalian, bacterial, yeast, algal, insect, and cell-free), reagents and instruments for transfection and cloning, growth reagents for cell culture during translation, and reagents and kits for downstream processes such as purification and characterization. It serves industries such as pharmaceuticals, biotechnology, academic & research institutes, CROs & CDMOs, and other industrial users, supporting applications in drug discovery, therapeutic development, and biochemical research, as well as other industries such as food and beverages, cosmetics, and textiles, among others.

Key Stakeholders

  • Protein Expression Instrument & Reagent Manufacturers
  • Suppliers of Expression Systems
  • National and regional research boards and organizations
  • Research & development companies
  • Clinical research organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Biotechnology companies
  • Research laboratories & academic institutes
  • Market research & consulting firms
  • Regulatory bodies

Report Objectives

  • To define, describe, and forecast the protein expression market by offering, type, workflow, scale of operation, protein modality, application, product end user, service end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall protein expression market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East [GCC (Saudi Arabia, United Arab Emirates, and the Rest of GCC) and the Rest of Middle East], and Africa
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Customization Options

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the Rest of Europe protein expression market, by country
  • Further breakdown of the Rest of Asia Pacific protein expression market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Segment Analysis

  • Cross-segment analysis

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Protein Expression Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Protein Expression Market

DMCA.com Protection Status